RTTNews | Jan 31, 2022 07:16AM EST

07:15 Monday, January 31, 2022 (RTTNews.com) - Altimmune: FDA Clears IND Application For Phase 2 Clinical Trial Of Pemvidutide For Obesity

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2022 RTTNews.com All Rights Reserved